Vis enkel innførsel

dc.contributor.authorCombes, Francis
dc.contributor.authorSofias, Alexandros Marios
dc.contributor.authorMc Cafferty, Séan
dc.contributor.authorHuysmans, Hanne
dc.contributor.authorDe Temmerman, Joyca
dc.contributor.authorHak, Sjoerd
dc.contributor.authorMeyer, Evelyne
dc.contributor.authorSanders, Niek N
dc.date.accessioned2022-05-02T10:51:51Z
dc.date.available2022-05-02T10:51:51Z
dc.date.created2020-02-03T18:04:57Z
dc.date.issued2019
dc.identifier.citationCancers. 2019, 11 (11), 1-14.en_US
dc.identifier.issn2072-6694
dc.identifier.urihttps://hdl.handle.net/11250/2993619
dc.description.abstractTumor associated macrophages are an essential part of the tumor microenvironment. Consequently, bone marrow-derived monocytes (BMDMs) are continuously recruited to tumors and are therefore seen as ideal delivery vehicles with tumor-targeting properties. By using immune cell depleting agents and macroscopic in vivo fluorescence imaging, we demonstrated that removal of endogenous monocytes and macrophages (but not neutrophils) leads to an increased tumor accumulation of exogenously administered BMDMs. By means of intravital microscopy (IVM), we confirmed our macroscopic findings on a cellular level and visualized in real time the migration of the donor BMDMs in the tumors of living animals. Moreover, IVM also revealed that clodronate-mediated depletion drastically increases the circulation time of the exogenously administered BMDMs. In summary, these new insights illustrate that impairment of the mononuclear phagocyte system increases the circulation time and tumor accumulation of donor BMDMs.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleMononuclear but Not Polymorphonuclear Phagocyte Depletion Increases Circulation Times and Improves Mammary Tumor-Homing Efficiency of Donor Bone Marrow-Derived Monocytesen_US
dc.title.alternativeMononuclear but Not Polymorphonuclear Phagocyte Depletion Increases Circulation Times and Improves Mammary Tumor-Homing Efficiency of Donor Bone Marrow-Derived Monocytesen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber1-14en_US
dc.source.volume11en_US
dc.source.journalCancersen_US
dc.source.issue11en_US
dc.identifier.doi10.3390/cancers11111752
dc.identifier.cristin1790447
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal